Global Ship Lease Reports Results for the First Quarter of 2018
Apr 30, 2018 12:30 pm UTC| Business
LONDON, April 30, 2018 -- Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership charter owner, announced today its unaudited results for the three months ended March 31, 2018. First Quarter Highlights ...
Orgenesis Appoints Professor Lorenzo Piemonti to Scientific Advisory Board
Apr 30, 2018 12:30 pm UTC| Business
GERMANTOWN, Md., April 30, 2018 -- Orgenesis Inc. (Nasdaq:ORGS), a manufacturer, service provider and developer of advanced cell therapies, today announced it has appointed Professor Lorenzo Piemonti, M.D., to the...
Pixelworks and Wanda Film Create Film Innovation & Ecosystem Lab
Apr 30, 2018 12:30 pm UTC| Business
SAN JOSE, Calif., April 30, 2018 -- Pixelworks, Inc. (NASDAQ:PXLW), a leading provider of visual processing solutions, today announced a collaboration with Wanda Film Group to set up a Film Innovation Ecosystem Lab in...
Imaging3 Announces Appointment of George Zdasiuk to Board of Directors
Apr 30, 2018 12:30 pm UTC| Business
BURBANK, Calif., April 30, 2018 -- Imaging3, Inc. (OTCQB:IGNG), a development stage company introducing disruptive technologies in the medical imaging industry, announced today the appointment of George Zdasiuk, PhD, to...
Cameo Resources Corp. Appoints New Board Member
Apr 30, 2018 12:30 pm UTC| Business
VANCOUVER, British Columbia, April 30, 2018 -- Cameo Resources Corp. (TSX Venture:CRU) (OTC:CRUUF) (FWB:SY7D) (the “Company” or “Cameo Resources”) is pleased to announce that Mr. Charnjit (Johnny) Singh Jagpal has been...
Byzen Digital Inc. Announces Appointment of Arthur Cory to Board of Directors
Apr 30, 2018 12:30 pm UTC| Business
Mr. Cory is Currently Chairman of Maule Minerales SA and the Anglo-Georgian Mining Company NEW YORK, NY, April 30, 2018 -- Byzen Digital Inc. (OTC PINK: EPSV), a newly formed early stage Blockchain technology...
Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin
Apr 30, 2018 12:30 pm UTC| Business
SAN DIEGO, April 30, 2018 -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) (“Cytori” or “the Company”) today provided an update on its plans for US manufacturing and EU approval for its ATI-0918 liposomal doxorubicin product....